News + Filings Transactions Holdings
All 13F 13D/G Other
|
Third Rock Ventures III, L.P.
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
02/14/2023 |
SC 13G/A
| Third Rock Ventures III, L.P. reports a 4.4% stake in Pliant Therapeutics, Inc. |
02/14/2023 |
SC 13G/A
| Third Rock Ventures III, L.P. reports a 4.5% stake in Fulcrum Therapeutics, Inc. |
02/14/2023 |
SC 13G/A
| Third Rock Ventures III, L.P. reports a 0.4% stake in Nurix Therapeutics, Inc. |
02/14/2023 |
SC 13G/A
| Third Rock Ventures III, L.P. reports a 2.2% stake in Revolution Medicines, Inc. |
02/14/2023 |
SC 13G/A
| Third Rock Ventures III, L.P. reports a 14.2% stake in Voyager Therapeutics, Inc. |
02/14/2022 |
SC 13G/A
| Third Rock Ventures III, L.P. reports a 10% stake in Fulcrum Therapeutics, Inc. |
02/14/2022 |
SC 13G
| Third Rock Ventures III, L.P. reports a 12.6% stake in Decibel Therapeutics, Inc. |
02/14/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/14/2022 |
SC 13G/A
| Third Rock Ventures III, L.P. reports a 5.7% stake in Nurix Therapeutics, Inc. |
02/14/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/16/2021 |
SC 13G
| Third Rock Ventures III, L.P. reports a 16.5% stake in Pliant Therapeutics, Inc. |
02/16/2021 |
SC 13G
| Third Rock Ventures III, L.P. reports a 14% stake in Nurix Therapeutics, Inc. |
02/16/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
02/16/2021 |
SC 13G
| Third Rock Ventures III, L.P. reports a 13.5% stake in Revolution Medicines, Inc. |
02/05/2020 |
SC 13G
| Third Rock Ventures III, L.P. reports a 25.5% stake in Fulcrum Therapeutics, Inc. |
02/13/2019 |
SC 13G
| Third Rock Ventures III, L.P. reports a 34.4% stake in Neon Therapeutics, Inc. |
02/13/2018 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/13/2018 |
SC 13G/A
| Third Rock Ventures III, L.P. reports a 30% stake in Voyager Therapeutics, Inc. |
02/13/2017 |
SC 13G/A
| Third Rock Ventures III, L.P. reports a 38.6% stake in Voyager Therapeutics, Inc. |
02/13/2017 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
|
|